Whole-tumor perfusion CT using texture analysis in unresectable stage IIIA/B non-small cell lung cancer treated with recombinant human endostatin | Zendy

Lei Shi | Zendy; Xiang-Lan Zhou | Zendy; Jing-Jing Sun | Zendy; Jie-Hui Huang | Zendy; Xu Wang | Zendy; Kai Li | Zendy; Pei-Pei Pang | Zendy; Yu-jin Xu | Zendy; Ming Chen | Zendy; Min-ming Zhang | Zendy

Open Access

Whole-tumor perfusion CT using texture analysis in unresectable stage IIIA/B non-small cell lung cancer treated with recombinant human endostatin

Author(s) -

Lei Shi,

Xiang-Lan Zhou,

Jing-Jing Sun,

Jie-Hui Huang,

Xu Wang,

Kai Li,

Pei-Pei Pang,

Yu-jin Xu,

Ming Chen,

Min-ming Zhang

Publication year - 2019

Publication title -

quantitative imaging in medicine and surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.766

H-Index - 21

eISSN - 2223-4292

pISSN - 2223-4306

DOI - 10.21037/qims.2019.06.05

Subject(s) - medicine , kurtosis , lung cancer , adenocarcinoma , perfusion , perfusion scanning , nuclear medicine , stage (stratigraphy) , coefficient of variation , pathology , cancer , biology , chemistry , paleontology , statistics , mathematics , chromatography

To observe the dynamic changes of blood perfusion with whole-tumor computed tomography (CT) perfusion imaging using texture analysis in patients with unresectable stage IIIA/B non-small cell lung cancer (NSCLC) treated with recombinant human endostatin (Endostar).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research